About the Company
We are a Singapore based pharmaceutical company incorporated with the intention of bringing niche therapeutic products to global markets. We are committed to connecting the markets where there is a clear and identified unmet medical need with those where the innovation to address such medical needs is being undertaken.
We have an established distribution network in 3 regions – Asia, Middle East, and Africa to service high growth markets.
The leadership team at Meraki Global has extensive operating experience and successful partnership with these distributors – a reliable relationship built over a decade.
We bring unique skill sets, functional expertise and on-ground experience which we intend to leverage to build a portfolio of products that addresses the unmet medical needs of these regions.
Our Leadership Team
Our Leadership Team
Our leaders bring more than 15 years of experience in the pharmaceutical industry across business development, drug development, project management, and international sales, coupled with a multi-geography in-depth experience across Europe, USA, Africa, South East Asia, and the Middle East.
The team has a demonstrated track record of registering, launching and establishing brands in these markets and has worked across various product forms including injectable products (including pure generics , Biological and Biotechnology based injectable).
Our Core Values
Accessible & Affordable Healthcare
Access to good quality healthcare should be a right for all and not be restricted by the ability to afford.
Trust and Transparency
Operating with complete Trust & Transparency with our customers, partners and employees.
We back our commitments, always and every time.
Early Stage Licensing
We work to co-develop high-quality pharmaceutical products in collaborative partnerships with other pharmaceutical companies with the intent to introduce them into the markets where we operate.
Late Stage Licensing
We specialize in identifying unmet medical needs in identified markets and on fulfilling those needs through licensing products from established companies globally.
Emerging markets will continue to be the primary growth drivers over the next few years for us. We have commercial operations in the following regions where we operate on direct to market models in majority of the countries.